Clinical trial
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
NCT00450086 · Dr. Falk Pharma GmbH, Industry · Completed
Key facts
| NCT number | NCT00450086 |
|---|---|
| Title | Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis |
| Official title | Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Budesonide Capsules vs. Mesalazine Granules vs. Placebo for Patients With Collagenous Colitis. |
| Lead sponsor | Dr. Falk Pharma GmbH, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Collagenous Colitis |
| Intervention type | Drug |
| Interventions | Budesonide, Mesalazine, Placebo |
| Enrollment | 92 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Mar 21, 2007 |
| Last update posted | May 19, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: